top of page
Three reasons to abandon low-density lipoprotein targets: an open letter to the Adult Treatment Panel IV of the National Institutes of Health
Hayward, Rodney A.; Krumholz, Harlan M.
Abstract:
Automatic Tags
Humans; Male; Adult; Evidence-Based Medicine; Cholesterol; United States; Practice Guidelines as Topic; Lipid Metabolism; Metabolic Diseases; Precision Medicine; Lipoproteins, LDL; Anticholesteremic Agents; Molecular Targeted Therapy; National Institutes of Health (U.S.); National Heart, Lung, and Blood Institute (U.S.)
bottom of page